D-0703-2017 Class III Terminated
FDA drug recall D-0703-2017 was initiated by Teva Pharmaceuticals USA on Mar 28, 2017 and is designated Class III. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Oct 24, 2017). Affected quantity: 49,089 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 17, 2017
- Initiation Date
- Mar 28, 2017
- Termination Date
- Oct 24, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 49,089 bottles
Product description
PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87
Reason for recall
Failed Stability Specifications
Distribution pattern
Nationwide
Code information
Lot # 94358; Exp. 05/17 Lot # 94920A; Exp. 07/17 Lot # 97083A; Exp. 12/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0703-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026